13. McIntosh GG, Lodge AJ, Watson P et al. NCL-CD10-270: a new monoclonal antibody recognising CD10 in paraffin-embedded tissue. Am. J. Pathol. 1999; 154; 77-82. 14. Kesse-Adu R, Shousha S. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative breast carcinoma. Mod. Pathol. 2004; 17; 646-652. 15. Tse GMK, Tsang AKH, Putti TC. et al. Stromal CD10 expression in mammary fibroadenoma and phyllodes tumours. J. Clin. Pathol. 2005; 58; 185-189. 16. Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod. Pathol. 2007; 20; 84-89. 17. Khanafshar E, Phillipson J, Schammel DP, Minobe L, Cymerman J, Weidner N. Inflammatory myofibroblastic tumor of the breast. Ann Diagn. Pathol. 2005; 9; 123-129. 18. Magro G, Caltabiano R, Di Cataldo A, Puzzo L. CD10 is expressed by mammary myofibroblastoma and spindle cell lipoma of soft tissue: an additional evidence of their histogenetic linking. Virchows Arch. 2007; 450; 727-728. 19. Leibl S, Moinfar F. Mammary NOS-type sarcoma with CD10 expression. A rare entity with features of myoepithelial differentiation. Am. J. Surg. Pathol. 2006; 30; 450-456.